Glenmark Pharmaceuticals Inc., USA recalls Potassium Chloride Extended-Release Capsules
FDA Class I
FDA classified this recall as Class I: the most serious kind, meaning there is a reasonable chance the product could cause serious health problems or death.
- Hazard
- Failed Dissolution Specifications
- Products
-
- Potassium Chloride Extended-Release Capsules
- Where it was sold
-
Nationwide
Nationwide
- Units affected
- 36,630 bottles
- About this recall
- Potassium Chloride Extended-Release Capsules, USP, (750 mg) 10 mEq K, 500-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Ltd. Plot No. 2, Phase-2, Pharma Zone SEZ, Pithampur, Dist.-Dhar, Madhya Pradesh 454 775, India, Manufactured for: Glenmark Pharmaceuticals Inc, USA, Mahwah, NJ 07430. NDC 68462-357-05